Centaurus Financial, Inc. Viatris Inc Transaction History

Centaurus Financial, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$9.95 - $12.27 $107,300 - $132,319	-10,784 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $5,562 - $8,731	-567 Reduced 5.0%	10,784 $117,000
Q4 2021 Feb 01, 2022	SELL	$12.09 - $14.68 $25,775 - $31,297	-2,132 Reduced 15.81%	11,351 $154,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $331 - $378	-25 Reduced 0.19%	13,483 $183,000
Q2 2021 Aug 10, 2021	BUY	$12.97 - $16.15 $47,379 - $58,995	3,653 Added 37.07%	13,508 $193,000
Q1 2021 Apr 30, 2021	SELL	$13.59 - $18.54 $21,146 - $28,848	-1,556 Reduced 13.64%	9,855 $138,000
Q4 2020 Jan 25, 2021	BUY	$14.3 - $18.74 $163,177 - $213,842	11,411 New	11,411 $214,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.